# عنوان نوع فایل سایز فایل بازدید دانلود امتیاز قیمت (تومان)
1
Update on the Management of Pediatric Chronic Hepatitis B
151.00 KB 48 0
رایگان
2
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation
2.74 MB 51 0
رایگان
3
Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection
130.70 KB 57 0
رایگان
4
Combination Therapy for Chronic Hepatitis B: Current Indications
149.66 KB 49 0
رایگان
5
Ribavirin: How Does it Work and is it Still Needed?
378.80 KB 61 0
رایگان
6
Hepatitis B Genotypes: Role of Testing in Clinical Practice
240.51 KB 63 0
رایگان
7
IL28B Polymorphisms as a Predictor of Response to Therapy in Genotype 1 Chronic Hepatitis C Infections
163.01 KB 55 0
رایگان
8
IL28B: Implications for Therapy
175.84 KB 50 0
رایگان
9
Management of Lower-Risk Myelodysplastic Syndromes: The Art and Evidence
247.52 KB 47 0
رایگان
10
The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate
304.65 KB 62 0
رایگان
11
Updates in Cytogenetics and Molecular Markers in MDS
194.91 KB 46 0
رایگان
12
What is the Best Frontline Therapy for Patients with CLL and 17p Deletion?
257.46 KB 56 0
رایگان
13
Late Effects of Childhood Leukemia Therapy
222.06 KB 61 0
رایگان
14
Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation
136.64 KB 47 0
رایگان
15
Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia
152.24 KB 54 1
رایگان
16
Treatment of Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients
270.25 KB 51 0
رایگان
17
New Drugs for Chronic Myelogenous Leukemia
177.94 KB 58 0
رایگان
18
Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?
176.99 KB 56 0
رایگان
19
Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy
238.22 KB 65 0
رایگان
20
The Role of Autologous Transplantation in Hodgkin Lymphoma
258.27 KB 56 0
رایگان
21
In Search of CML Stem Cells’ Deadly Weakness
144.67 KB 50 0
رایگان
22
The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma
166.73 KB 82 0
رایگان
23
Chronic Myelogenous Leukemia: Monitoring Response to Therapy
147.09 KB 75 0
رایگان
24
Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?
203.77 KB 79 0
رایگان
25
Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling
198.62 KB 55 0
رایگان
Update on the Management of Pediatric Chronic Hepatitis B

Update on the Management of Ped ...

A primary challenge in the management of pediatric chronic hepatitis B (CHB) is the lack of established child-specific guidelines. Treatment decisio ...

151.00 KB
رایگان
New and Evolving Management Paradigms for Hepatitis C after Liver Transplantation

New and Evolving Management Par ...

Hepatitis-C induced liver failure is the leading indication for liver transplantation in the United States, and the burden of hepatitis C virus (HCV ...

2.74 MB
رایگان
Update on the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Virus Infection

Update on the Risk of Hepatocel ...

Chronic hepatitis B virus infection is an important cause of liver-related morbidity and mortality, with hepatocellular carcinoma being the most lif ...

130.70 KB
رایگان
Combination Therapy for Chronic Hepatitis B: Current Indications

Combination Therapy for Chronic ...

Hepatitis B infection remains a major public health problem globally and in the United States, with significant use of healthcare resources. Several ...

149.66 KB
رایگان
Ribavirin: How Does it Work and is it Still Needed?

Ribavirin: How Does it Work and ...

Ribavirin is a synthetic guanosine analogue, which acts against hepatitis C virus (HCV) through several mechanisms that include 1) immune modulation ...

378.80 KB
رایگان
Hepatitis B Genotypes: Role of Testing in Clinical Practice

Hepatitis B Genotypes: Role of ...

Hepatitis B viral genotypes influence natural history, with genotype Cmore likely to develop hepatocellular carcinoma than genotype B, thus influenc ...

240.51 KB
رایگان
IL28B Polymorphisms as a Predictor of Response to Therapy in Genotype 1 Chronic Hepatitis C Infections

IL28B Polymorphisms as a Predic ...

Hepatitis C virus (HCV) is the most common cause of chronic liver disease in the United States. There are more than 170 million cases worldwide, and ...

163.01 KB
رایگان
IL28B: Implications for Therapy

IL28B: Implications for Therapy

Within the last 2 years, a number of Genome- Wide Association Studies (GWAS) have shown that single nucleotide polymorphisms (SNPs) in the interleuk ...

175.84 KB
رایگان
Management of Lower-Risk Myelodysplastic Syndromes: The Art and Evidence

Management of Lower-Risk Myelod ...

Myelodysplastic syndromes (MDS) represent a spectrum of bone marrow failure with variable outcome. Patients with “lower-risk” disease have an expect ...

247.52 KB
رایگان
The Relevance of Iron Overload and the Appropriateness of Iron Chelation Therapy for Patients with Myelodysplastic Syndromes: A Dialogue and Debate

The Relevance of Iron Overload ...

Accumulation of excessive amounts of iron in vulnerable organs and tissues, together with elevated plasma and intracellular concentrations of reacti ...

304.65 KB
رایگان
Updates in Cytogenetics and Molecular Markers in MDS

Updates in Cytogenetics and Mol ...

Myelodysplastic syndromes (MDS) are clonal hematologic neoplasms that can result in cytopenias and increase the risk of leukemic transformation. The ...

194.91 KB
رایگان
What is the Best Frontline Therapy for Patients with CLL and 17p Deletion?

What is the Best Frontline Ther ...

Chronic lymphocytic leukemia (CLL) is a lymphoproliferative disease with significant variation in disease progression, response to therapy, and surv ...

257.46 KB
رایگان
Late Effects of Childhood Leukemia Therapy

Late Effects of Childhood Leuke ...

As survival rates for children treated for childhood cancers become significantly better, the focus is increasingly on determining the late effects ...

222.06 KB
رایگان
Treatment of Newly Diagnosed Myeloma in Patients not Eligible for Transplantation

Treatment of Newly Diagnosed My ...

Melphalan plus prednisone (MP) has long been considered the gold-standard treatment for elderly patients with newly diagnosed myeloma, and it still ...

136.64 KB
رایگان
Role of Tyrosine Kinase Inhibitors in the Management of Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Role of Tyrosine Kinase Inhibit ...

The Philadelphia chromosome is the most common cytogenetic abnormality found in adult patients diagnosed with acute lymphoblastic leukemia. The resu ...

دانلود 1
152.24 KB
رایگان
Treatment of Newly Diagnosed Multiple Myeloma in Transplant-Eligible Patients

Treatment of Newly Diagnosed Mu ...

Treatment of myeloma has changed significantly in the past decade as a result of better understanding of disease biology, more effective treatments, ...

270.25 KB
رایگان
New Drugs for Chronic Myelogenous Leukemia

New Drugs for Chronic Myelogeno ...

The introduction of tyrosine kinase inhibitors (TKIs) has changed the landscape of therapy for chronic myelogenous leukemia (CML). Once considered a ...

177.94 KB
رایگان
Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?

Can Low-Risk, Early-Stage Patie ...

Advances in the treatment of Hodgkin lymphoma since about 1970 have led to a remarkable improvement in the long-term outcomes of what was once cons ...

176.99 KB
رایگان
Predicting the Response of CML Patients to Tyrosine Kinase Inhibitor Therapy

Predicting the Response of CML ...

As of 2011, the choice of tyrosine kinase inhibitor (TKI) for the patient with newly diagnosed chronic-phase chronic myelogenous leukemia (CP-CML) ...

238.22 KB
رایگان
The Role of Autologous Transplantation in Hodgkin Lymphoma

The Role of Autologous Transpla ...

Between 80% and 90% of Hodgkin lymphoma (HL) patients can be cured with up-to-date combinedmodality treatments, but patients with disease refractory ...

258.27 KB
رایگان
In Search of CML Stem Cells’ Deadly Weakness

In Search of CML Stem Cells’ De ...

Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder that is characterized by the presence of a fusion oncogene, BCR-ABL, which en ...

144.67 KB
رایگان
The Unique Characteristics and Management of Patients Over 60 Years of Age with Classic Hodgkin Lymphoma

The Unique Characteristics and ...

In recent decades, the prognosis of Hodgkin lymphoma has been substantially improved, but these successes have been restricted to younger patients a ...

166.73 KB
رایگان
Chronic Myelogenous Leukemia: Monitoring Response to Therapy

Chronic Myelogenous Leukemia: M ...

Molecular monitoring is a key component of the management of patients with chronic myeloid leukemia. The current recommendation is that molecular mo ...

147.09 KB
رایگان
Primary Mediastinal Large B-Cell Lymphoma, Classic Hodgkin Lymphoma Presenting in the Mediastinum, and Mediastinal Gray Zone Lymphoma: What is the Oncologist To Do?

Primary Mediastinal Large B-Cel ...

In recent years, an overlap in biologic and clinical features has been identified between classic Hodgkin lymphoma (CHL) and primary mediastinal lar ...

203.77 KB
رایگان
Impact of Diabetes on Postinfarction Heart Failure and Left Ventricular Remodeling

Impact of Diabetes on Postinfar ...

Diabetes mellitus, the metabolic syndrome, and the underlying insulin resistance are increasingly associated with diastolic dysfunction and reduced ...

198.62 KB
رایگان

بارگزاری